Treatment research progress of primary immune thrombocytopenia / 中国基层医药
Chinese Journal of Primary Medicine and Pharmacy
;
(12): 253-256, 2019.
Artículo
en Chino
| WPRIM
| ID: wpr-733935
ABSTRACT
Primary immune thrombocytopenia is an autoimmune disease characterized by reduced platelets, accompanied by or without skin mucous bruises,epistaxis,internal bleeding,etc. Recent years,the treatment of primary immune thrombocytopenia developed very quickly, including the appearance of platelet receptor agonist - Eltrom-bopag. Here,we reviewed the treatment and research development of primary immune thrombocytopenia.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Idioma:
Chino
Revista:
Chinese Journal of Primary Medicine and Pharmacy
Año:
2019
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS